Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

NCT05212610 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Corona Virus Infection

Interventions

BIOLOGICAL: Pfizer-BioNTech mRNA COVID-19 vaccine
BIOLOGICAL: Moderna mRNA COVID-19 vaccine

Sponsor

University of Michigan

Collaborators

[object Object]